Skip to main content

Animations

MJFF Publications

4501 - 4510 of 9038 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian Efficacy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30175
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Enrichment analysis for spatial and single-cell metabolomics accounting for molecular ambiguity
    Journal Name: Bioinformatics Advances
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioadv/vbaf100
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Longitudinal assessment of the association between pesticide exposure and lifestyle with Parkinson’s disease motor severity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01010-2
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2025.1582362
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Clinical correlates of data-driven subtypes of deep gray matter atrophy and dopamine availability in early Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01037-5
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cts.13720
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01041-9
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Parkinson's disease‐linked Kir4.2 mutation R28C leads to loss of ion channel function
    Journal Name: The Journal of Physiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1113/jp287046
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Loss‐of‐function coding variants in the Ras of complex proteins/ GTPase domain of leucine rich repeat kinase 2
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/pro.70190
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Harmonization of Structural Brain Connectivity Through Distribution Matching
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/hbm.70257
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.